Navigation Links
myMatrixx's Phil Walls, R.Ph. Receives National and Regional Recognition
Date:10/5/2011

TAMPA, Fla., Oct. 5, 2011 /PRNewswire/ -- myMatrixx®, a full-service pharmacy and ancillary medical benefits management company for worker's compensation, announced today that Phil Walls, R.Ph., Chief Clinical & Compliance Officer, has been named a finalist in two prestigious awards programs. The first is Health Care Heroes hosted by the Tampa Bay Business Journal in which Phil is a finalist in the Medical Professional Non-Physician category. Phil will be recognized with other honorees at an awards ceremony on October 13 for making a significant impact in the region's health care community.

(Logo: http://photos.prnewswire.com/prnh/20111005/FL81065LOGO)

Phil has also been named a finalist in The Dorland Health People Awards, a national program recognizing healthcare professionals in the Pharmacist category. The Dorland awards honors individuals who are making a difference in transitioning the patient through the complicated healthcare landscape. Phil will be honored at an awards ceremony in Washington, D.C., on October 20 where the award winners will be announced.

"All of us at myMatrixx are extremely proud of Phil and the recognition he has received both regionally and nationally," stated Steven MacDonald, CEO of myMatrixx. "His contribution to the clinical programs we provide our clients has been crucial to our success and I cannot think of anyone more deserving of these honors," added MacDonald.

Joseph Paduda of Health Strategy Associates agrees, "Phil is very knowledgeable about the complex issues inherent in managing drug therapy in workers' comp. Phil's ability to combine that knowledge with practical experience and compassion for the injured worker is apparent to anyone who has worked closely with him," added Paduda.

For more information on the Health Care Heroes Awards visit the Tampa Bay Business Journal website and for the Dorland Heath People Awards visit the Dorland Health website.

About myMatrixx myMatrixx is a full-service pharmacy and ancillary medical benefits management company focusing on the "Customer Experience." The company's Technology Plus™ platform and approach combines advanced technology, expert clinical support, productivity-improving processes, real-time alerts and comprehensive reporting to simplify the management of worker's compensation claims. The result is a reduction of costs and improved outcomes for clients and their injured workers. Contact:Lori Taylor, Director of Marketing and Communications(877) 804-4900, ext 136 or ltaylor@mymatrixx.com
'/>"/>

SOURCE myMatrixx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
2. Bioness Inc. Receives FDA Clearance and CE Mark for Its NESS H200 Wireless System for Hand Paralysis as a Result of Stroke and Other Central Nervous System Disorders
3. Siemens Mobilett Mira Mobile Digital X-Ray System Receives FDA Clearance
4. Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™
5. Awarepoint Corporation Receives Frost & Sullivans 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award
6. Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)® to Treat Amyotrophic Lateral Sclerosis (ALS)
7. Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding
8. Kimberly-Clark Health Care Receives Landmark FDA Clearance for Pediatric Face Mask
9. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
10. American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11. ULURU Inc. Receives NYSE Amex Notice of Non-Compliance with Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... LAKES, N.J. , Sept. 12, 2017  Consumer reviews on ... Embrace Hearing as the number one company for hearing aids, ... ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):